Fostering translation of genetics research: an NIDDK perspective

Personalized Medicine
Beena AkolkarRebekah S Rasooly

Abstract

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the NIH, supports a large and varied portfolio of genetic research grants and contracts. As a funding agency, the NIDDK aims to support research that can be translated into discoveries that help to reduce the burden of genetic diseases. Except for the major advances in diagnostics for Mendelian diseases and a few disease-specific therapies, there has only been modest clinical benefit from the investment in human genetics research. For genetically complex, multifactorial diseases, including many of the common diseases in the USA, the risk genes are harder to find than for Mendelian diseases, and translation seems even further off. How can NIDDK make its investment in human genetics research pay off? This report describes the challenges in human genetics research and NIDDK's fivefold funding strategy to support science that will eventually lead to meaningful translation.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Mar 10, 2001·Recent Progress in Hormone Research·S A KliewerT M Willson
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Nov 16, 2004·Science·Christopher P AustinFrancis S Collins
Jan 29, 2005·Journal of the American Society of Nephrology : JASN·Andrew D PatersonYork Pei
Mar 23, 2005·Kidney International·Pamela R FainRobert W Schrier
Aug 27, 2005·Expert Opinion on Biological Therapy·H Bobby Gaspar, Adrian J Thrasher
Sep 22, 2005·JAMA : the Journal of the American Medical Association·Elias A Zerhouni
Apr 28, 2007·Science·UNKNOWN Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical RShaun Purcell
May 5, 2007·Science·Anna HelgadottirKari Stefansson
May 5, 2007·Science·Ruth McPhersonJonathan C Cohen
Jul 20, 2007·The New England Journal of Medicine·Nilesh J SamaniUNKNOWN WTCCC and the Cardiogenics Consortium
Dec 13, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Muin J KhouryLinda Bradley
Feb 19, 2008·The Journal of Gene Medicine·Corinna LebherzJames M Wilson
Sep 17, 2008·Nature Genetics·W H Linda KaoUNKNOWN Family Investigation of Nephropathy and Diabetes Research Group
Sep 25, 2008·Current Opinion in Pulmonary Medicine·Joseph M Collaco, Garry R Cutting
Oct 18, 2008·Nature Reviews. Genetics·Frank JohannesRitsert C Jansen
Oct 23, 2008·Lancet·Yuri A Zarate, Robert J Hopkin
Nov 8, 2008·Science·David AltshulerEric S Lander
Dec 10, 2008·Expert Opinion on Biological Therapy·Joel Charrow
Dec 11, 2008·JAMA : the Journal of the American Medical Association·Amy L McGuire, Wylie Burke
Jan 14, 2009·Advanced Drug Delivery Reviews·Uta GriesenbachUNKNOWN UK Cystic Fibrosis Gene Therapy Consortium
Feb 17, 2009·Trends in Genetics : TIG·Marcia L BudarfJohn D Rioux
Feb 27, 2009·Nature·YuanYuan GuChristopher L Karp
Mar 31, 2009·Nature Genetics·Shahana AhmedDouglas F Easton
Apr 17, 2009·The New England Journal of Medicine·Peter Kraft, David J Hunter
Apr 17, 2009·The New England Journal of Medicine·David B Goldstein
Apr 17, 2009·The New England Journal of Medicine·Joel N Hirschhorn
May 7, 2009·The Journal of Clinical Endocrinology and Metabolism·Mark I McCarthy
Jun 6, 2009·Journal of Internal Medicine·R R GrahamT W Behrens

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.